BHB810 A CDH17-directed antibody-drug conjugate in Phase 1 development for gastric and other advanced gastrointestinal cancers.
Visit productCosigns Received
Be the first Cosign
Put your name behind BHB810.
Add it to your Products I use list and share why you use it.